Original Article
Transhepatic Direct Approach to the “Limit of the Division of the Hepatic Ducts” Leads to a High R0 Resection Rate in Perihilar Cholangiocarcinoma

https://doi.org/10.1007/s11605-020-04891-1Get rights and content

Abstract

Background

Previous studies have shown that curative resection (R0 resection) was among the most crucial factors for the long-term survival of patients with PHCC. To achieve R0 resection, we performed the transhepatic direct approach and resection on the limits of division of the hepatic ducts. Although a recent report showed that the resection margin (RM) status impacted PHCC patients’ survival, it is still unclear whether RM is an important clinical factor.

Objective

To describe a technique of transhepatic direct approach and resection on the limit of division of hepatic ducts, investigate its short-term surgical outcome, and validate whether the radial margin (RM) would have a clinical impact on long-term survival of perihilar cholangiocarcinoma (PHCC) patients.

Methods

Consecutive PHCC patients (n = 211) who had undergone major hepatectomy with extrahepatic bile duct resection, without pancreaticoduodenectomy, in our department were retrospectively evaluated.

Results

R0 resection rate was 92% and 86% for invasive cancer-free and both invasive cancer-free and high-grade dysplasia-free resection, respectively. Overall 5-year survival rate was 46.9%. Univariate analysis showed that preoperative serum carcinoembryonic antigen level (> 7.0 mg/dl), pathological lymph node metastasis, and portal vein invasion were independent risk factors, but R status on both resection margin and bile duct margin was not an independent risk factor for survival.

Conclusion

The transhepatic direct approach to the limits of division of the bile ducts leads to the highest R0 resection rate in the horizontal margin of PHCC. Further examination will be needed to determine the adjuvant therapy for PHCC to improve patient survival.

Introduction

Previous reports have shown that curative resection (R0 resection) was among the most crucial long-term survival factors in patients with perihilar cholangiocarcinoma (PHCC).1,2 Several studies conducted at high-volume centers showed R0 resection rate for PHCC of 63–83.2%.2., 3., 4., 5., 6., 7., 8., 9., 10., 11., 12. To achieve R0 resection, Kondo et al.1 (our department) previously advocated guidelines for PHCC surgery and reported that surgery under these guidelines could lead to a high R0 resection rate with no mortality. This guideline included the concept of “transhepatic direct approach to the limits dividing the hepatic ducts from the vasculature and ductal division”: an intrahepatic duct goes behind and is covered by a portal branch, which should be preserved; the point where the bile duct cannot be further separated from the vasculature is “intrahepatic bile duct resection on limit of dividing of the hepatic ducts,” which is an anatomically regulated point, and we believed it is unique in each type of hepatectomy,13 which could lead R0 resection on horizontal bile ductal margin (BM) in PHCC.

Today, “a transhepatic direct approach to the bile duct” would begin to be the standard procedure for PHCC surgery.14., 15., 16. However, only a few surgeons have performed the transhepatic direct approach to “the limits of division of the bile ducts”; thus, only a few reports have described this surgical technique.13,17., 18., 19. Moreover, there has been no study investigating the short- and long-term results of this technique. Although a recent report showed that the RM status impacted PHCC patients’ survival, it is still unclear whether radial margin (RM) is an important clinical factor.

Thus, we aimed to describe our technique of transhepatic direct approach to the limits of division of the bile duct and investigate the short-term surgical outcome of this technique, including R status on BM/RM, mortality, and morbidity.

Section snippets

New Guideline for PHCC Surgery

In 2004, we upgraded our guideline for PHCC and performed resections based on the upgraded guideline. Our upgraded guideline for PHCC was as follows:

  • Preoperative tumor progression for both BM and RM should be diagnosed by using multi-detector row computed tomography (MD-CT), direct cholangiography, and magnetic resonance cholangiopancreatography (MRCP).

  • The proper type of major hepatectomy with caudate lobectomy should be selected and be performed based on preoperative diagnosis and assessment.

Results

During the study period, we performed 211 cases of PHCC surgery with curative intent. The characteristics of the patients in this study are shown in Table 1. The pathological results are shown in Table 2. The R0 resection rates were 92% and 86% for invasive cancer-free resection and both high-grade dysplasia (HGD) and invasive cancer-free resection, respectively. Nine (4.2%) out of the 210 patients were cancer positive on RM, but not on BM. The overall 5-year survival rate was 46.9%. The

Discussion

In 2004, Kondo et al. advocated not only the original concept of “limiting the resection of the bile duct “ but revealed that major hepatectomy, not only Bismuth types III and IV but also Bismuth types I and II, would lead to a better long term-prognosis.1 Therefore, we upgraded our guideline for PHCC in 2004.

“Intrahepatic bile duct resection on the limit of the division of the bile ducts” with our upgraded guideline could lead to the highest R0 resection rate in the recent decade.2,8., 9., 10.

Conclusion

The transhepatic direct approach to the limits of the division of the bile ducts leads to the highest R0 resection rate in the horizontal margin of PHCC. However, patients with RM-R1 and BM-R1 had poor prognosis. Moreover, these patients with “classical risk factors” also had a poor prognosis. Further examination will be needed to determine the adjuvant therapy for PHCC to improve survival in PHCC.

Conflict of Interest

The authors declare that they have no conflict of interest.

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References (39)

  • S. Kondo et al.

    Forty consecutive resections of hilar cholangiocarcinoma with no postoperative mortality and no positive ductal margins: results of a prospective study

    Ann Surg.

    (2004)
  • Shinohara K, Ebata T, Shimoyama Y, Mizuno T, Yokoyama Y, Yamaguchi J et al. A Study on Radial Margin Status in Resected...
  • S.G. Lee et al.

    Surgical treatment of hilar cholangiocarcinoma in the new era: the Asan experience

    J Hepatobiliary Pancreat Sci.

    (2010)
  • H. Shimizu et al.

    Aggressive surgical resection for hilar cholangiocarcinoma of the left-side predominance: radicality and safety of left-sided hepatectomy

    Ann Surg.

    (2010)
  • K. Matsuo et al.

    The Blumgart preoperative staging system for hilar cholangiocarcinoma: analysis of resectability and outcomes in 380 patients

    J Am Coll Surg.

    (2012)
  • Q.B. Cheng et al.

    Resection with total caudate lobectomy confers survival benefit in hilar cholangiocarcinoma of Bismuth type III and IV

    Eur J Surg Oncol.

    (2012)
  • S.C. Song et al.

    Surgical outcomes of 230 resected hilar cholangiocarcinoma in a single centre

    ANZ J Surg.

    (2013)
  • N. Furusawa et al.

    Surgical treatment of 144 cases of hilar cholangiocarcinoma without liver-related mortality

    World J Surg.

    (2014)
  • R. Higuchi et al.

    Surgical Outcomes for Perihilar Cholangiocarcinoma with Vascular Invasion

    J Gastrointest Surg.

    (2019)
  • R. Matsuyama et al.

    Our Rationale of Initiating Neoadjuvant Chemotherapy for Hilar Cholangiocarcinoma: A Proposal of Criteria for "Borderline Resectable" in the Field of Surgery for Hilar Cholangiocarcinoma

    World J Surg.

    (2019)
  • P.B. Olthof et al.

    A comparison of treatment and outcomes of perihilar cholangiocarcinoma between Eastern and Western centers

    HPB (Oxford).

    (2019)
  • T.B. Tran et al.

    Actual 5-Year Survivors After Surgical Resection of Hilar Cholangiocarcinoma

    Ann Surg Oncol.

    (2019)
  • S. Hirano et al.

    Treatment strategy for hilar cholangiocarcinoma, with special reference to the limits of ductal resection in right-sided hepatectomies

    J Hepatobiliary Pancreat Surg.

    (2007)
  • C. De Lu et al.

    Total Hilar En Bloc Resection with Left Hemihepatectomy and Caudate Lobectomy: a Novel Approach for Treatment of Left-Sided Perihilar Cholangiocarcinoma (with Video)

    J Gastrointest Surg.

    (2017)
  • H. Kamachi et al.

    Transparenchymal glissonean approach: a novel surgical technique for advanced perihilar bile duct cancer

    Langenbecks Arch Surg.

    (2018)
  • N. Kuriyama et al.

    Transhepatic Hilar Approach for Perihilar Cholangiocarcinoma: Significance of Early Judgment of Resectability and Safe Vascular Reconstruction

    J Gastrointest Surg.

    (2017)
  • M. Nagino et al.

    "Anatomic" right hepatic trisectionectomy (extended right hepatectomy) with caudate lobectomy for hilar cholangiocarcinoma

    Ann Surg.

    (2006)
  • K. Uesaka

    Left hepatectomy or left trisectionectomy with resection of the caudate lobe and extrahepatic bile duct for hilar cholangiocarcinoma (with video)

    J Hepatobiliary Pancreat Sci.

    (2012)
  • S. Govil et al.

    Surgical resection techniques for locally advanced hilar cholangiocarcinoma

    Langenbecks Arch Surg.

    (2014)
  • Cited by (0)

    View full text